Unravelling c-Met signalling from autophagic endomembranes
解开自噬内膜的 c-Met 信号传导
基本信息
- 批准号:MR/R009732/1
- 负责人:
- 金额:$ 52.09万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Our body is composed of billions of cells. These cells are constantly exchanging information in the form of signals, which is crucial for them to act in a coordinated fashion. These signals can induce cell multiplication, movement, and cell death. This communication is often initiated by the interaction of two proteins: a ligand and a receptor. Ligands bind to the receptors, which are normally present at the surface of cells, to transmit signals from outside the cell. The receptors then activate additional proteins, called signal transducers, to transmit the signals to the inside of the cell, where they are interpreted and alter the cell's behaviour. Cells must tightly control the activity of these receptors because deregulated receptor activity can lead to diseases, such as chronic inflammation or cancer. Thus, there is a need to better understand how receptors operate so that they can be corrected when they go wrong. A cell is like a town, and each building block in a cell has a role. Autophagy is one of these blocks; it is like a household waste recycling centre: cell waste are sent to autophagic sites to be destroyed and recycled. Surprisingly we recently find out that in cancer cells, these recycling centre were hijacked for some "illegal activities": we have found that receptors responsible for cancer go there not to be degraded but on the contrary to be even more active. This new scientific concept changes our understanding of how receptors operate. It opens new challenges to understand how receptors transmit information to signal transducers inside the cell, and why receptor activity on autophagic sites, as opposed to activity at the cell surface, is required to modulate cell behaviour. We propose investigating this concept using one receptor model, c-Met. This receptor plays a major role in controlling cell growth, cell survival and cell movement, thus contributing to proper organ function and renewal. It is also deregulated in diseases such as chronic inflammation and cancer and therefore need to be targeted in these conditions. We aim to fully understand the mechanisms necessary for c-Met to transmit signals from autophagic sites. To achieve our objectives we will use state of the art cell biology, imaging and biochemistry techniques. In particular, we will use a novel technique that allows the capturing of all the partners of c-Met that are present on autophagic sites.Our work will lead to the discovery of novel molecular mechanisms controlling receptor activity. Our results should benefit researchers working on receptors, signal transducers, cell growth, cell survival and cell movement, both within the UK and internationally. Since autophagic c-Met activity accounts for the aggressiveness of certain tumours, our research could also benefit researchers working on cancer. Furthermore, given that c-Met is necessary for proper organ function and renewal, our results may have an impact in the fields of regenerative medicine and ageing. Thus the beneficiaries of this research include pharmaceutical companies, the public health domain (NHS) and patients.
我们的身体由数十亿个细胞组成。这些细胞不断地以信号的形式交换信息,这对它们协调行动至关重要。这些信号可以诱导细胞增殖、运动和细胞死亡。这种通讯通常是由两种蛋白质的相互作用引发的:一种配体和一种受体。配体与通常存在于细胞表面的受体结合,以从细胞外传递信号。然后,受体激活额外的蛋白质,称为信号转导,将信号传递到细胞内部,在那里它们被解释并改变细胞的行为。细胞必须严格控制这些受体的活性,因为受体活性失调可能导致疾病,如慢性炎症或癌症。因此,有必要更好地了解受体是如何运作的,以便在它们出错时能够得到纠正。细胞就像一个城镇,细胞中的每一块积木都有自己的角色。自噬就是其中之一;它就像一个家庭废物回收中心:细胞废物被送到自噬场所进行销毁和回收。令人惊讶的是,我们最近发现,在癌细胞中,这些回收中心被劫持了一些“非法活动”:我们发现,负责癌症的受体去那里不是为了降解,而是相反,更加活跃。这个新的科学概念改变了我们对受体如何运作的理解。它开启了新的挑战,以了解受体如何将信息传递到细胞内的信号转导器,以及为什么自噬位点上的受体活性(而不是细胞表面的活性)需要调节细胞行为。我们建议使用一种受体模型c-Met来研究这一概念。这种受体在控制细胞生长、细胞存活和细胞运动中起着重要作用,从而有助于正常的器官功能和更新。它在慢性炎症和癌症等疾病中也是失调的,因此需要在这些疾病中靶向治疗。我们的目标是充分了解c-Met从自噬位点传递信号所必需的机制。为了实现我们的目标,我们将使用最先进的细胞生物学,成像和生物化学技术。特别是,我们将使用一种新的技术,允许捕获所有的合作伙伴的c-Met是目前的自噬sites.我们的工作将导致发现新的分子机制控制受体的活动。我们的研究结果应该有利于研究受体,信号转导,细胞生长,细胞存活和细胞运动的研究人员,无论是在英国还是国际上。由于自噬c-Met活性是某些肿瘤侵袭性的原因,我们的研究也可能使癌症研究人员受益。此外,鉴于c-Met是正常器官功能和更新所必需的,我们的研究结果可能会对再生医学和衰老领域产生影响。因此,这项研究的受益者包括制药公司,公共卫生领域(NHS)和患者。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
MET exon 14 skipping mutation is a hepatocyte growth factor (HGF)-dependent oncogenic driver in vitro and in humanised HGF knock-in mice.
- DOI:10.1002/1878-0261.13397
- 发表时间:2023-11
- 期刊:
- 影响因子:6.6
- 作者:Fernandes, Marie;Hoggard, Brynna;Jamme, Philippe;Paget, Sonia;Truong, Marie-Jose;Gregoire, Valerie;Vinchent, Audrey;Descarpentries, Clotilde;Morabito, Angela;Stanislovas, Justas;Farage, Enoir;Meneboo, Jean-Pascal;Sebda, Sheherazade;Bouchekioua-Bouzaghou, Katia;Nollet, Marie;Humez, Sarah;Perera, Timothy;Fromme, Paul;Grumolato, Luca;Figeac, Martin;Copin, Marie-Christine;Tulasne, David;Cortot, Alexis B.;Kermorgant, Stephanie;Kherrouche, Zoulika
- 通讯作者:Kherrouche, Zoulika
Proximity interactome of LC3B in normal growth conditions
- DOI:10.1101/2021.10.08.463639
- 发表时间:2021-10
- 期刊:
- 影响因子:0
- 作者:M. Nollet;A. Agrotis;Fanourios Michailidis;Arran Dokal;V. Rajeeve;J. Burden;T. Nightingale;P. Cutillas;R. Ketteler;S. Kermorgant
- 通讯作者:M. Nollet;A. Agrotis;Fanourios Michailidis;Arran Dokal;V. Rajeeve;J. Burden;T. Nightingale;P. Cutillas;R. Ketteler;S. Kermorgant
c-Met-integrin cooperation: Mechanisms, tumorigenic effects, and therapeutic relevance.
- DOI:10.3389/fcell.2022.994528
- 发表时间:2022
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
The role of MET in chemotherapy resistance.
- DOI:10.1038/s41388-020-01577-5
- 发表时间:2021-03
- 期刊:
- 影响因子:8
- 作者:Wood GE;Hockings H;Hilton DM;Kermorgant S
- 通讯作者:Kermorgant S
Unconventional role of RAC1 in MET-driven anchorage-independent tumor growth.
- DOI:10.1080/23723556.2020.1803029
- 发表时间:2020-08-18
- 期刊:
- 影响因子:2.1
- 作者:Hervieu A;Kermorgant S
- 通讯作者:Kermorgant S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Stephanie Kermorgant其他文献
The interplay between Met and autophagy in PDAC
- DOI:
10.1016/j.pan.2018.10.030 - 发表时间:
2020-12-01 - 期刊:
- 影响因子:
- 作者:
Alejandro Noval;Katherine Fletcher;Oliver Florey;Stephanie Kermorgant - 通讯作者:
Stephanie Kermorgant
Hepatocyte growth factor (HGF) induces human colon cancer cell invasiveness via enhanced motility, protease overproduction, PI3 kinase- and PKC-dependent pathways
- DOI:
10.1016/s0016-5085(00)85570-5 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:2.4
- 作者:
Stephanie Kermorgant;Thomas Aparicio;Valerie Dessirier;Miguel J. Lewin;Therese Lehy - 通讯作者:
Therese Lehy
Glycine-extended gastrin-17 (G17-Gly) and amidated G17 (G17-NH2) induce the invasiveness of colon cancer epithelial NH2 cells in vitro
- DOI:
10.1016/s0016-5085(00)85206-3 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Stephanie Kermorgant;Valerie Dessirier;Therese Lehy - 通讯作者:
Therese Lehy
Hepatocyte growth factor (HGF) activates some cellular events involved in enterocyte-like differentiation of colon cancer epithelial cells
- DOI:
10.1016/s0016-5085(00)84370-x - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Stephanie Kermorgant;Valerie Dessirier;Miguel Mjm Lewin;Therese Lehy - 通讯作者:
Therese Lehy
Leptin secretion and leptin receptor in human stomach
- DOI:
10.1016/s0016-5085(00)82203-9 - 发表时间:
2000-04-01 - 期刊:
- 影响因子:
- 作者:
Iradj Sobhani;Christiane Vissuzaine;Marion Buyse;Stephanie Kermorgant;Jean-Pierre Laigneau;Dominique Henin;Andre Bado;Miguel JM Lewin - 通讯作者:
Miguel JM Lewin
Stephanie Kermorgant的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Stephanie Kermorgant', 18)}}的其他基金
C-Met internalisation and tumour cell migration
C-Met 内化和肿瘤细胞迁移
- 批准号:
G0501003/1 - 财政年份:2007
- 资助金额:
$ 52.09万 - 项目类别:
Research Grant
相似国自然基金
复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
- 批准号:2025JJ70694
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
抗体药物偶联物(ADC)阻断MET通路对骨肉瘤靶向治疗的研究
- 批准号:2025JJ80738
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Gal9+TAMs经旁分泌塑造新型Gal9-Met互作轴驱动肝癌免疫逃逸的分子机制及干预策略
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
时序释放Met/Qct-MPs葡萄糖响应型水凝胶对糖尿病创面微环境调节机制的研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
安罗替尼通过调控HGF/c-MET信号通路与自噬相互作用促进人脑胶质瘤细胞凋亡的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
MET介导代谢修饰调控肌-骨线粒体转移促进衰老状态骨再生的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
新型靶向c-MET/EGFR小分子抑制剂ZP-32克服EGFR TKI MET扩增耐药的非小细胞肺癌脑转作用及机制研究
- 批准号:2025JJ70229
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于核酸适体的原位共价标记技术用于精准高效调控
c-Met 蛋白功能
- 批准号:2024JJ6017
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
非小细胞肺癌 MET-TKI 获得性耐药的分子机制探索及药物筛选
- 批准号:2024JJ7468
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
RNASET2缺失触发胆固醇介导的MET磷酸化促进肝癌侵袭转移的机
制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
肝細胞増殖因子受容体METの糖鎖によるHGFシグナル制御メカニズムの解析
肝细胞生长因子受体MET糖链调控HGF信号机制分析
- 批准号:
24K19089 - 财政年份:2024
- 资助金额:
$ 52.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
頭頸部癌におけるEGFR及びMET糖鎖異常の解明
阐明头颈癌中 EGFR 和 MET 聚糖异常
- 批准号:
24K19774 - 财政年份:2024
- 资助金额:
$ 52.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
肝細胞増殖因子HGFによるMet受容体活性化機構の構造学的研究
肝细胞生长因子HGF激活Met受体机制的结构研究
- 批准号:
23K21290 - 财政年份:2024
- 资助金额:
$ 52.09万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
複数の臓器移植・転移モデルを用いたMET阻害薬およびHGF活性化阻害薬治療効果検証
使用多器官移植/转移模型验证MET抑制剂和HGF激活抑制剂的治疗效果
- 批准号:
24K19671 - 财政年份:2024
- 资助金额:
$ 52.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of novel treatment targeting the HGF/MET pathway in metastatic CRPC
针对转移性 CRPC 中 HGF/MET 通路的新型治疗方法的开发
- 批准号:
23K08737 - 财政年份:2023
- 资助金额:
$ 52.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Magneto-enhancement technology for solid state batteries (MET-SSB).
固态电池磁增强技术(MET-SSB)。
- 批准号:
10079564 - 财政年份:2023
- 资助金额:
$ 52.09万 - 项目类别:
BEIS-Funded Programmes
Diverging roles of EGFR and MET in acetaminophen-induced acute liver injury
EGFR 和 MET 在对乙酰氨基酚诱导的急性肝损伤中的不同作用
- 批准号:
10633557 - 财政年份:2023
- 资助金额:
$ 52.09万 - 项目类别:
The Role of Non-Coding RNA Editing in MET Signaling in NSCLC
非编码 RNA 编辑在 NSCLC MET 信号转导中的作用
- 批准号:
10573620 - 财政年份:2023
- 资助金额:
$ 52.09万 - 项目类别: